Project Number 1R43AG063675-01A1 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Fluorescence lifetime platform to discover small-molecule inhibitors of tau and alpha-synuclein oligomerization. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) i. Proteostasis/Proteinopathies Researcher and Organization Principal Investigator THOMAS, JENNIFER JEWELL Principal Investigator First Name JENNIFER Principal Investigator Last Name THOMAS Awardee Organization PHOTONIC PHARMA, LLC Awardee State Minnesota Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-18-188: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) FY Overall Cost $593,889 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
